CCDC18

gene
On this page

Also known as NY-SAR-41

Summary

CCDC18 (coiled-coil domain containing 18, HGNC:30370) is a protein-coding gene on chromosome 1p22.1, encoding Coiled-coil domain-containing protein 18 (Q5T9S5). May promote pre-adipocyte differentiation.

Located in centriolar satellite.

Source: NCBI Gene 343099 — RefSeq curated summary.

At a glance

  • GWAS associations: 8
  • Clinical variants (ClinVar): 243 total — 1 pathogenic
  • MANE Select transcript: NM_001378204

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:30370
Approved symbolCCDC18
Namecoiled-coil domain containing 18
Location1p22.1
Locus typegene with protein product
StatusApproved
AliasesNY-SAR-41
Ensembl geneENSG00000122483
Ensembl biotypeprotein_coding
OMIM621137
Entrez343099

Gene structure

Transcript identifiers

Ensembl transcripts: 21 — 13 protein_coding, 5 nonsense_mediated_decay, 2 protein_coding_CDS_not_defined, 1 retained_intron

ENST00000343253, ENST00000370276, ENST00000401026, ENST00000421014, ENST00000447456, ENST00000448243, ENST00000455267, ENST00000479653, ENST00000481180, ENST00000528942, ENST00000688770, ENST00000690025, ENST00000690592, ENST00000692873, ENST00000935051, ENST00000935052, ENST00000935053, ENST00000935054, ENST00000935055, ENST00000956828, ENST00000956829

RefSeq mRNA: 3 — MANE Select: NM_001378204 NM_001306076, NM_001378204, NM_206886

CCDS: CCDS41356, CCDS76180, CCDS91004

Canonical transcript exons

ENST00000690025 — 29 exons

ExonStartEnd
ENSE000008311569323624893236390
ENSE000013336409323968393239896
ENSE000014522359327846393278730
ENSE000014522399327034793270814
ENSE000034906199326470193264901
ENSE000034956629325447193254614
ENSE000035006349322160993221743
ENSE000035092389319200093192106
ENSE000035314929320551093205631
ENSE000035337979318336093183495
ENSE000035492869320710793207398
ENSE000035609039323242693232593
ENSE000035736909321474393214966
ENSE000035839879318634593186503
ENSE000035906089321210193212261
ENSE000035945469325874893258885
ENSE000035947249321773893217869
ENSE000035951739320189293201988
ENSE000035973089325633593256538
ENSE000036045029318397893184146
ENSE000036063609323931093239473
ENSE000036364209322633393226449
ENSE000036530609324683893246954
ENSE000036611399321080293210926
ENSE000036652249322185993221936
ENSE000036654979319361693193744
ENSE000036732259321663693216746
ENSE000036847269324610593246204
ENSE000039365899318072493180852

Expression profiles

Bgee: expression breadth ubiquitous, 171 present calls, max score 90.52.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 6.6146 / max 129.6984, expressed in 1516 samples.

FANTOM5 promoters (3 alternative TSS)

Promoter IDTPM avgSamples expressed
40585.09001211
2015771.2319745
40570.2927104

Top tissues by expression

245 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047390.52gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099188.94gold quality
ventricular zoneUBERON:000305388.39gold quality
bone marrow cellCL:000209284.86gold quality
left testisUBERON:000453382.00gold quality
calcaneal tendonUBERON:000370181.99gold quality
right testisUBERON:000453481.66gold quality
oocyteCL:000002381.62gold quality
testisUBERON:000047381.57gold quality
ganglionic eminenceUBERON:000402380.61gold quality
monocyteCL:000057680.33gold quality
granulocyteCL:000009480.26gold quality
leukocyteCL:000073880.06gold quality
right lobe of liverUBERON:000111477.71gold quality
adrenal tissueUBERON:001830377.03gold quality
spleenUBERON:000210677.02gold quality
colonic epitheliumUBERON:000039776.99gold quality
lymph nodeUBERON:000002976.88gold quality
vermiform appendixUBERON:000115476.82gold quality
gastrocnemiusUBERON:000138876.45gold quality
stromal cell of endometriumCL:000225576.41gold quality
thymusUBERON:000237075.89gold quality
muscle of legUBERON:000138375.86gold quality
hindlimb stylopod muscleUBERON:000425275.24gold quality
tendonUBERON:000004375.06gold quality
rectumUBERON:000105275.05gold quality
right lungUBERON:000216774.43gold quality
bone marrowUBERON:000237174.25gold quality
mucosa of transverse colonUBERON:000499174.25gold quality
lower esophagus mucosaUBERON:003583474.10gold quality

Single-cell (SCXA)

Detected in 3 experiment(s), a significant marker in 3.

ExperimentMarker?Max mean expression
E-MTAB-9543yes19.12
E-CURD-112yes18.99
E-ANND-3yes5.61

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

27 targeting CCDC18, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-3163100.0077.238605
HSA-MIR-5692A100.0074.406850
HSA-MIR-428299.9975.366408
HSA-MIR-548P99.9872.253784
HSA-MIR-497-5P99.9271.832674
HSA-MIR-10527-5P99.9172.283754
HSA-MIR-130599.9171.433443
HSA-MIR-15A-5P99.9072.802787
HSA-MIR-15B-5P99.9072.782798
HSA-MIR-16-5P99.9072.802780
HSA-MIR-195-5P99.9072.812805
HSA-MIR-374A-5P99.9071.342923
HSA-MIR-374B-5P99.9069.982734
HSA-MIR-548E-5P99.8972.734486
HSA-MIR-95-5P99.8972.173973
HSA-MIR-424-5P99.8971.902641
HSA-MIR-6838-5P99.8971.942690
HSA-MIR-153-5P99.8973.866317
HSA-MIR-221-3P99.8671.561329
HSA-MIR-222-3P99.8671.351337
HSA-MIR-548AJ-5P99.7871.123085
HSA-MIR-548F-5P99.7871.023093
HSA-MIR-548G-5P99.7871.123085
HSA-MIR-548X-5P99.7871.123085
HSA-MIR-315498.9466.551455
HSA-MIR-556-5P97.7566.17473
HSA-MIR-61096.8467.98905

Cross-species orthologs

4 orthologs

OrganismSymbolGene ID
danio_rerioccdc18ENSDARG00000078822
danio_reriosi:ch73-389b16.1ENSDARG00000101586
mus_musculusCcdc18ENSMUSG00000056531
rattus_norvegicusCcdc18ENSRNOG00000024545

Paralogs (2): DEUP1 (ENSG00000165325), CEP63 (ENSG00000182923)

Protein

Protein identifiers

Coiled-coil domain-containing protein 18Q5T9S5 (reviewed: Q5T9S5)

Alternative names: Sarcoma antigen NY-SAR-24

All UniProt accessions (11): A0A8I5KNM5, A0A8I5KRA2, A0A8I5KUE1, A0A8I5KWA2, E9PFB9, Q5T9S5, H0YCD6, H0YDP2, H7C0C9, J3KP97, Q5T9S2

UniProt curated annotations — full annotation on UniProt →

Function. May promote pre-adipocyte differentiation.

Subcellular location. Cytoplasm. Cytoskeleton. Microtubule organizing center. Centrosome. Centriolar satellite.

Isoforms (2)

UniProt IDNamesCanonical?
Q5T9S5-11yes
Q5T9S5-22

RefSeq proteins (3): NP_001293005, NP_001365133, NP_996769 (=MANE)

Domains & families (InterPro)

UniProt features (15 total): sequence conflict 6, coiled-coil region 4, modified residue 2, chain 1, region of interest 1, splice variant 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q5T9S5-F171.830.08

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (2): 45, 1355

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 116 (showing top): GOCC_MICROTUBULE_ORGANIZING_CENTER, GOCC_CENTROSOME, PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP, DODD_NASOPHARYNGEAL_CARCINOMA_UP, FISCHER_DREAM_TARGETS, GOBP_CONNECTIVE_TISSUE_DEVELOPMENT, GOBP_POSITIVE_REGULATION_OF_DEVELOPMENTAL_PROCESS, chr1p22, GOBP_ADIPOSE_TISSUE_DEVELOPMENT, TGGAAA_NFAT_Q4_01, GOBP_POSITIVE_REGULATION_OF_MULTICELLULAR_ORGANISMAL_PROCESS, MARSON_BOUND_BY_FOXP3_STIMULATED, MARSON_BOUND_BY_FOXP3_UNSTIMULATED, GOCC_CENTRIOLAR_SATELLITE, GEORGES_TARGETS_OF_MIR192_AND_MIR215

GO Biological Process (1): positive regulation of adipose tissue development (GO:1904179)

GO Molecular Function (0):

GO Cellular Component (3): centriolar satellite (GO:0034451), cytoplasm (GO:0005737), cytoskeleton (GO:0005856)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
cellular anatomical structure2
positive regulation of developmental process1
positive regulation of multicellular organismal process1
adipose tissue development1
regulation of adipose tissue development1
centrosome1
intracellular anatomical structure1
intracellular membraneless organelle1

Protein interactions and networks

STRING

738 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
CCDC18CCDC14Q49A88648
CCDC18PRADC1Q9BSG0588
CCDC18KIAA0753Q2KHM9521
CCDC18PRSS37A4D1T9509
CCDC18CCDC13Q8IYE1489
CCDC18CEP126Q9P2H0478
CCDC18TMEM35BQ8NCS4478
CCDC18KLHDC8AQ8IYD2477
CCDC18CCDC12Q8WUD4476
CCDC18SFXN4Q6P4A7471
CCDC18UACAQ9BZF9470
CCDC18NUDT7P0C024464
CCDC18TMEM71Q6P5X7441
CCDC18ZNF490Q9ULM2430
CCDC18CCDC66A2RUB6423

IntAct

41 interactions, top by confidence:

ABTypeScore
MED4MED19psi-mi:“MI:2364”(proximity)0.900
PRPF19AQRpsi-mi:“MI:0914”(association)0.790
DYNLL1BLTP3Bpsi-mi:“MI:0914”(association)0.730
GALK2POTEFpsi-mi:“MI:0914”(association)0.530
EMILIN1METTL15psi-mi:“MI:0914”(association)0.530
CDR2IGSF3psi-mi:“MI:0914”(association)0.530
COG3TBCCpsi-mi:“MI:0914”(association)0.530
NDEL1OFD1psi-mi:“MI:0914”(association)0.530
CCDC13CEP290psi-mi:“MI:0914”(association)0.460
Cep135psi-mi:“MI:0914”(association)0.350
Ska1HSPD1psi-mi:“MI:0914”(association)0.350
Cep131WBP2psi-mi:“MI:0914”(association)0.350
OFD1CCDC14psi-mi:“MI:0914”(association)0.350
Lrrcc1CCDC14psi-mi:“MI:0914”(association)0.350
FAM167ASHTN1psi-mi:“MI:0914”(association)0.350
NDEL1SHTN1psi-mi:“MI:0914”(association)0.350
SYCE1RABGAP1Lpsi-mi:“MI:0914”(association)0.350
BFSP1RABGAP1Lpsi-mi:“MI:0914”(association)0.350
COMTAP1G1psi-mi:“MI:0914”(association)0.350
CENPQZFC3H1psi-mi:“MI:0914”(association)0.350
GLRXHPRT1psi-mi:“MI:0914”(association)0.350
CEP128CCDC66psi-mi:“MI:2364”(proximity)0.270
OFD1PSMD14psi-mi:“MI:2364”(proximity)0.270
PCM1CCDC66psi-mi:“MI:2364”(proximity)0.270
ODF2CCDC66psi-mi:“MI:2364”(proximity)0.270
CEP135CCDC66psi-mi:“MI:2364”(proximity)0.270
POC5PSMD14psi-mi:“MI:2364”(proximity)0.270
CEP63CCDC66psi-mi:“MI:2364”(proximity)0.270
EYA2CNOT1psi-mi:“MI:2364”(proximity)0.270

BioGRID (96): CCDC18 (Affinity Capture-MS), CCDC18 (Proximity Label-MS), CCDC18 (Proximity Label-MS), CCDC18 (Proximity Label-MS), CCDC18 (Proximity Label-MS), CCDC18 (Proximity Label-MS), CCDC18 (Proximity Label-MS), CCDC18 (Proximity Label-MS), CCDC18 (Proximity Label-MS), CCDC18 (Affinity Capture-MS), CCDC18 (Affinity Capture-MS), CCDC18 (Affinity Capture-MS), CCDC18 (Affinity Capture-MS), CCDC18 (Affinity Capture-MS), CCDC18 (Affinity Capture-MS)

ESM2 similar proteins: A6QR54, A8WG43, A9UM82, B2RZ86, B3DLE8, E9Q1U1, P0CAP1, Q08B20, Q08DR9, Q0VBY1, Q2T9U2, Q3SWS9, Q3UIJ9, Q4R7H3, Q4R8C3, Q53EZ4, Q5DTN8, Q5EB94, Q5M9N0, Q5PQ23, Q5RI56, Q5T9S5, Q5ZKK5, Q640L5, Q66H89, Q6NRC9, Q6NRW2, Q6P5D4, Q6TFL3, Q6ZU80, Q70FJ1, Q7ZW57, Q8BI22, Q8BVL9, Q8CDI6, Q8CDI7, Q8HYY4, Q8IUD2, Q8N998, Q8NCX0

Diamond homologs: Q5T9S5, Q640L5, Q9PW73

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 58 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Activation of BAD and translocation to mitochondria7140.2×2e-12
Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex7123.8×3e-12
SARS-CoV-1 targets host intracellular signalling and regulatory pathways7123.8×3e-12
Activation of BH3-only proteins791.5×3e-11
RHO GTPases activate PKNs758.4×5e-10
Intrinsic Pathway for Apoptosis753.9×7e-10
FOXO-mediated transcription544.2×8e-07
Loss of Nlp from mitotic centrosomes937.6×5e-11

GO biological processes:

GO termPartnersFoldFDR
substantia nigra development643.1×1e-06
protein targeting535.9×4e-05
intracellular protein localization1020.5×2e-08

Disease & clinical

Clinical variants and AI predictions

ClinVar

243 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic1
Likely pathogenic0
Uncertain significance169
Likely benign20
Benign17

Top pathogenic / likely-pathogenic (1)

Variant IDHGVSClassification
151368GRCh38/hg38 1p22.1(chr1:92490929-93507291)x1Pathogenic

SpliceAI

5317 predictions. Top by Δscore:

VariantEffectΔscore
1:93180052:A:ACdonor_gain1.0000
1:93180053:C:CTdonor_gain1.0000
1:93183357:A:AGacceptor_gain1.0000
1:93183358:A:Gacceptor_gain1.0000
1:93183359:GAAAT:Gacceptor_gain1.0000
1:93183976:A:AGacceptor_gain1.0000
1:93183977:G:GGacceptor_gain1.0000
1:93186339:TTTCA:Tacceptor_loss1.0000
1:93186340:TTCAG:Tacceptor_loss1.0000
1:93186341:TCAGA:Tacceptor_loss1.0000
1:93186342:CA:Cacceptor_loss1.0000
1:93186343:A:ACacceptor_loss1.0000
1:93186344:G:GTacceptor_loss1.0000
1:93186344:GAT:Gacceptor_gain1.0000
1:93186504:G:GGdonor_gain1.0000
1:93191994:TTTTA:Tacceptor_loss1.0000
1:93191996:TTAG:Tacceptor_loss1.0000
1:93191997:TA:Tacceptor_loss1.0000
1:93191998:A:AGacceptor_gain1.0000
1:93191999:G:GGacceptor_gain1.0000
1:93192104:GAG:Gdonor_gain1.0000
1:93192105:AGGT:Adonor_loss1.0000
1:93192106:GGTA:Gdonor_loss1.0000
1:93192107:G:Cdonor_loss1.0000
1:93192107:G:GGdonor_gain1.0000
1:93192108:T:Adonor_loss1.0000
1:93193613:T:Gacceptor_gain1.0000
1:93193613:TA:Tacceptor_loss1.0000
1:93193614:A:AGacceptor_gain1.0000
1:93193614:AG:Aacceptor_loss1.0000

AlphaMissense

9740 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
1:93193620:G:CA192P0.997
1:93201914:G:CA241P0.997
1:93201926:G:CA245P0.997
1:93214926:T:CL559P0.997
1:93246185:T:CL1020P0.997
1:93183447:T:CL29P0.996
1:93246199:G:CA1025P0.996
1:93201936:T:CL248P0.995
1:93246164:T:CL1013P0.995
1:93232511:T:CL792P0.994
1:93239881:T:CL988P0.993
1:93246196:G:CA1024P0.993
1:93192075:G:CA180P0.992
1:93201918:T:CL242P0.992
1:93216679:T:CL587P0.992
1:93226343:T:CL728P0.992
1:93232448:T:CL771P0.992
1:93239809:T:CL964P0.992
1:93239830:T:CL971P0.992
1:93201907:G:CR238S0.991
1:93201907:G:TR238S0.991
1:93232562:T:CL809P0.991
1:93236270:T:CL827P0.991
1:93239893:T:CL992P0.991
1:93193633:T:CL196P0.990
1:93214830:T:CL527P0.990
1:93214842:T:CL531P0.990
1:93216667:T:CL583P0.990
1:93246195:A:CR1023S0.990
1:93246195:A:TR1023S0.990

dbSNP variants (sampled 300 via entrez): RS1000006426 (1:93224022 C>A), RS1000027098 (1:93212537 A>G), RS1000038747 (1:93212873 A>G), RS1000054194 (1:93262740 C>T), RS1000210042 (1:93228044 A>G), RS1000241019 (1:93228312 G>A), RS1000270723 (1:93179014 C>G), RS1000321081 (1:93259611 G>T), RS1000419562 (1:93204728 C>T), RS1000431545 (1:93262176 C>T), RS1000445489 (1:93185778 A>G), RS1000456892 (1:93186079 G>A), RS1000478785 (1:93252773 C>T), RS1000485068 (1:93234901 T>G), RS1000545849 (1:93226635 G>A,C)

Disease associations

OMIM: gene MIM:621137 | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

8 associations (top):

StudyTraitp-value
GCST004600_64Eosinophil percentage of white cells3.000000e-11
GCST004606_168Eosinophil count1.000000e-12
GCST004617_56Eosinophil percentage of granulocytes2.000000e-10
GCST004623_148Neutrophil percentage of granulocytes7.000000e-10
GCST004624_194Sum eosinophil basophil counts8.000000e-12
GCST007733_30Serum uric acid levels5.000000e-07
GCST008477_35Emphysema annual change measurement in smokers (adjusted lung density)5.000000e-06
GCST90002402_483Platelet count9.000000e-12

EFO canonical traits (8, from GWAS)

EFO IDTrait name
EFO:0007991eosinophil percentage of leukocytes
EFO:0004842eosinophil count
EFO:0007996eosinophil percentage of granulocytes
EFO:0007994neutrophil percentage of granulocytes
EFO:0005090basophil count
EFO:0004761uric acid measurement
EFO:0007626emphysema imaging measurement
EFO:0004309platelet count

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

54 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
trichostatin Aaffects cotreatment, decreases expression, increases expression3
Valproic Acidincreases expression, decreases expression3
Cyclosporinedecreases expression, increases expression3
sodium arsenitedecreases expression, increases expression2
Tetrachlorodibenzodioxindecreases expression2
Cadmium Chlorideincreases expression2
GSK-J4decreases expression1
dicrotophosdecreases expression1
methylmercuric chloridedecreases expression1
triphenyl phosphateaffects expression1
propionaldehydedecreases expression1
sulforaphaneincreases expression1
butyraldehydedecreases expression1
manganese chlorideincreases abundance, increases expression1
benzo(e)pyreneincreases methylation1
potassium chromate(VI)affects cotreatment, decreases expression1
ferrous chloridedecreases expression1
nickel sulfatedecreases expression1
1-nitropyreneincreases expression1
epigallocatechin gallateaffects cotreatment, decreases expression1
avobenzonedecreases expression1
microcystin RRincreases expression1
CGP 52608affects binding, increases reaction1
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamideaffects cotreatment, decreases expression1
2,2’,4,4’,5-brominated diphenyl etherdecreases expression1
abrinedecreases expression1
dorsomorphinaffects cotreatment, decreases expression1
jinfukangaffects cotreatment, decreases expression1
incobotulinumtoxinAdecreases expression1
2,3,5-trichloro-6-phenyl-(1,4)benzoquinoneincreases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.